| NCT ID | NCT01467869 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Miami |
| Condition | Spinal Cord Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 1991-01 |
| Primary Completion | 2035-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 1991-01 with a primary completion date of 2035-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Following spinal cord injury, most men are infertile and require medical assistance to father children. The conditions that contribute to their infertility are erectile dysfunction, ejaculatory dysfunction, and semen abnormalities. The Miami Project Male Fertility Program is a research study designed to understand and improve impairments to male fertility resulting from spinal cord injury.
Eligibility Criteria
Inclusion Criteria: * Any man with spinal cord injury over the age of 18. Control Subjects will be any healthy man over the age of 18 with no recent history of infertility Exclusion Criteria: * Women will be excluded.
Contact & Investigator
Emad Ibrahim, MD
PRINCIPAL INVESTIGATOR
University of Miami
Frequently Asked Questions
Who can join the NCT01467869 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 50 Years, studying Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01467869 currently recruiting?
Yes, NCT01467869 is actively recruiting participants. Contact the research team at oxp210@miami.edu for enrollment information.
Where is the NCT01467869 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT01467869 clinical trial?
NCT01467869 is sponsored by University of Miami. The principal investigator is Emad Ibrahim, MD at University of Miami. The trial plans to enroll 100 participants.